The National Prostate Cancer Audit (NPCA) has published its latest annual report. Based on data from men diagnosed with, or treated for, prostate cancer between 1 April 2019 and 31 March 2020 in England and Wales, the report assesses the care provided and outcomes in addition to the impact of COVID-19.
The report found that the number of men diagnosed with prostate cancer in England and Wales was 45,885. This is an increase on the number reported for 2017-18 (42,668) but down from the unusually high number for 2018-19 (52,850). Other findings include:
The proportion of men presenting with metastatic disease at diagnosis in England and Wales is stable at 13%.
The proportion of men recorded as having an emergency readmission within 90 days of radical prostate cancer surgery is 13%, similar to the 14% reported in 2020, and
Medium-term outcomes are similar or better than previous years, including the finding that genitourinary complications following radical prostatectomy have reduced slightly since last year’s report. 7% of men experienced at least one genitourinary complication within two years of their prostatectomy compared to 9% the previous year.
The report also found that the COVID-19 pandemic had a profound impact on the care provided to patients with cancer, with delays in diagnosis and treatment, including:
A 54% reduction in the number of patients newly diagnosed with prostate cancer during April-June 2020 compared with the same period from 2019, and
A 48% reduction in the number of men undergoing radical prostatectomy from April – June 2020 compared with 2019 (21% vs 17%).
Read the full report: You can read the report by clicking on the link below.
Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
